Cubist Daptomycin VRE Pivotal Trial May Include Synercid Comparison
Executive Summary
Pivotal trials for Cubist's daptomycin antibiotic against vancomycin-resistant Enterococcus are expected to include a comparative arm with Rhone-Poulenc Rorer's Synercid (quinupristin/dalfopristin).